Funding for this research was provided by:
Text and Data Mining valid from 2018-11-17
Received: 30 July 2018
Accepted: 10 November 2018
First Online: 17 November 2018
Compliance with ethical standards
: H. Al-Samkari has a consultancy with Agios. E. Van Cott declares she has no conflict of interest. D. Kuter has received research funding from the following: Protalex, Bristol-Myers Squibb, Rigel, Bioverativ, Agios, Syntimmune, Principia, Alnylam; consultancy with the following: ONO, Pfizer, 3SBios, Eisai, GlaxoSmithKline, Genzyme, Shire, Amgen, Shionogi, Rigel, Syntimmune, MedImmune, Novartis, Bioverativ, Argenx, Zafgen; and does paid expert testimony for Amgen and CRICO.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.